fda semaglutide news The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing US FDA says two more

Bariatric surgery--which seeks to reduce the size of the stomach or bypass part of the GI tract--was conceived in the 1960s when surgeons observed that gastric cancer patients who had part of the stomach removed (subtotal gastrectomy) went on to lose weight

Glossary of Terms References Jastreboff AM, Kaplan LM, Frias JP, et al

Metformin pharmacogenomics: current status and future directions

Potential for Hypoglycemia: Although less common when used alone, semaglutide can cause hypoglycemia (low blood sugar) when used with other glucose-lowering medications, such as insulin or sulfonylureas

Overall, its important to talk to your healthcare provider before making any changes or trying a new drug

However, the included trials were conducted on relatively small sample sizes, which may limit the ability to detect rare psychiatric outcomes